- 1Biomaterial and Tissue Engineering Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
- 2Faculty of New Science and Technology, University of Tehran (UT), Tehran, Iran
- 3Department of Nanotechnology and Advanced Material, Materials and Energy Research Center (MERC), Karaj, Iran
- 4Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
Bisphosphonates (BPs) such as Zoledronic acid (ZA) are a subset of synthetic small molecules, which are now marketed as the main drugs to stimulate the growth and differentiation of osteoblast cells, thereby increasing bone formation as well as preventing bone loss. Also, Halloysite Nanotubes (HNTs)-polymer composites have attracted a lot of attention due to their high surface-to-volume ratio, low density, and high hydrophilicity, and are easily dispersed in hydrophilic biopolymers. In addition, their ability to carry enough amounts of drugs and the ability to control release has been demonstrated. Based on studies, the Gelatin-based scaffold with Halloysite nanotube (HNT) has the capacity as a drug carrier and Zoledronic acid (ZA) sustains release. Previous studies show that using ZA intravenously has some severe side effects and limitations. But by attention to the advantages of its osteogenesis, the current study has been done in order to reduce the side effects of local delivery of it. The 3-dimensional scaffolds were prepared by the Freeze-drying method. Characterization methods such as FE-SEM, FTIR, XRD, and release behavior of the scaffold has been performed to evaluate the features of the scaffolds. In fact, as-prepared Gel-HNT/ZA release 49% ZA in Phosphate Buffered Saline (PBS) within 21 days. The mechanical properties have been increased after adding HNTs and ZA from 10.27 to 26.18 MPa. Also, the water absorption has been increased after adding HNTs and ZA from 1.67 to 5.02 (g/g). Seeded human Adipose stem cells (hASCs) on the prepared scaffolds showed that the ZA effectively elevated the proliferation of the hASCs and also the MTT results proved the non-toxicity of all prepared scaffolds by high cell viability (˃80%). The osteogenic differentiation has been accelerated as displayed by ALP and Ca assay. The results propose that the HNTs-loaded Gelatin scaffold could control the releasing of ZA and its localized delivery at the defect site, simultaneously promoting the mechanical and osteogenesis ability of gelatin-based scaffolds.
1 Introduction
An important and big class of orthopedic problems is bone defects (Wiese and Pape, 2010; Guerado and Caso, 2017; Gage et al., 2018; Kim et al., 2020). Over the last few decades, many efforts have been made by researchers to find suitable bone replacements. Early efforts focused on the use of metal substitutes. However, corrosion of these implants in the patient’s body, in addition to their mechanical properties and gradual loosening, led to the release of highly toxic metal ions and subsequent inflammatory reactions of these products with the surrounding tissue (Parks and Lakes, 1992). Another problem with metals is their very high modulus (Liu and Dixit, 1997). The elastic modulus of metals is higher than 100 GPa, which will be much higher than the density of dense bone (6–20 GPa). The result of this high stiffness is the occurrence of the phenomenon of stress protection on the growing bone, which will lead to thinning of the new bone tissue and will increase the probability of its re-failure (Flahiff et al., 1996). Problems such as this have drawn the attention of many researchers to newer materials; Materials that do not have the problems of previous implants and at the same time allow the formation of bone tissue in the defect position with higher speed and quality. Thus, a new chapter called “Bone Tissue Engineering” was opened and new biomaterials for this purpose were introduced to the medical community (Park and Bronzino, 2000; Burg et al., 2000; Lee et al., 2001). It has been reported that the production of novel scaffolds as the carrier for osteogenesis drugs could be an advantageous approach to eschew systemic problems of the drug while improving its therapeutic efficiency (Cartmell, 2009; Xu et al., 2020).
Small molecules are natural or synthetic molecules that have low molecular weight and have the ability to regulate cellular, tissue, and therapeutic functions. These molecules are organic in nature and have less than 1,000 Da in size (Carbone et al., 2014). Bisphosphonates (BPs) are a subset of small molecules, small synthetic compounds, and now marketed as the main drugs to stimulate the growth and differentiation of osteoblast cells, thereby increasing bone formation as well as preventing bone loss.
BPs have been shown to reduce the risk of vertebral and non-vertebral fractures (Lambrinoudaki et al., 2006). They are pyrophosphate analogues that have been modified to act as a specific stimulant of osteogenesis and anti-bone resorption, the mechanism of which is to have a strong inhibitory effect on osteoclasts and increase bone induction. BPs have a strong affinity for bone surfaces and accumulate there, and due to this selective action, they have systemic side effects. BPs are also potent bone resorption inhibitors that inhibit osteoclast differentiation (Coxon et al., 2000) and stimulate the programmatic death of osteoclast cells (Benford et al., 2001). The results show a high tendency of BPs to bone mineralization and especially the return of lost bone volume (Nancollas et al., 2006). Using of bisphosphonates is considered, as one of the applicable methods that can be increased the integration of scaffolds with the surrounding bone tissue by increasing bone growth, for example, Zoledronic acid (ZA), which is a member of this group. (Yang et al., 2020).
In recent decades, Halloysite Nanotubes (HNTs)-polymer composites have attracted a lot of attention due to their high surface-to-volume ratio, low density and high hydrophilicity, and are easily dispersed in hydrophilic biopolymers (Ji et al., 2017; Zare and Rhee, 2021c; Zare and Rhee, 2021b). In addition, HNTs have shown excellent mechanical properties and good biocompatibility (Abdollahi Boraei et al., 2020a; Abdollahi Boraei et al., 2021a; Zare and Rhee, 2022). HNT-containing polymer nanocomposite scaffolds have been shown to be capable of carrying sufficient amounts of drugs as well as their controlled release (Zare et al., 2021). Also, the opposite charge on the outer and inner surface of HNTs makes them attractive for electrostatic bonding with polymers and drugs (Lee Y. J. et al., 2019; Zare and Rhee, 2021a).
In the present study, a gelatin based-nanocomposite with HNTs containing of Zoledronic acid was used for bone regeneration, with the aim of targeting ZA release in a controlled manner. This new drug delivery system is designed as a novel nanocomposite system for use in bone tissue engineering. Also, HNT was also used as a carrier of ZA drug, which strengthened the specificity of the system. Moreover, improving the physical, mechanical and bone properties of gelatin scaffolds has been expected by using this composition. The application of BTE is evaluated by making a specific scaffold in combination with gelatin. Gelatin was selected as a matrix of scaffold due to its non-toxicity, low cost, availability, ease of processing, high cell adhesion and proliferation (Ji et al., 2017). Finally, the effects of both HNT and ZA loading on the biological properties of gelatin-based scaffolds were evaluated in vitro and in vivo.
2 Materials and Methods
2.1 Loading of ZA on/into HNTs
At the first, HNTs (4 mg/ml; Sigma Co.) were added to ZA supersaturated solution (4 mg/ml; Sigma Co.) mixed in deionized water under vacuum situation. After 20 min, the suspension was removed, stirred vigorously overnight and then centrifuged for 20 min with 6,000 rpm. The obtained precipitates were washed thoroughly and then freeze dried.
2.2 Preparation and Characterization of Scaffolds
2.2.1 Preparation
Gelatin (2.4 g; sigma, Type A) was poured in 40 ml of deionized water to be dissolved at room temperature and HNTs (4 wt. % relative to gelatin) and ZA-loaded HNTs were added to the solution of gelatin. After stirring thoroughly, the prepared suspensions were dispensed in 24 well tissue culture plates, kept in the refrigerator at 4°C for 24 h and finally frozen at –80°C overnight before doing freeze-drying process (OPERON Company, Korea). Moreover, pure gelatin scaffold without HNTs was chosen as the control group. The prepared scaffolds were coded as 1) Gel (without HNTs), 2) Gel/HNTs (without ZA), and 3) Gel/HNT-ZA (with ZA). Then, the cross linking of scaffolds was done in a sealed desiccator in the presence of glutaraldehyde (8 ml) at 37°C for 4 h. Afterward, the prepared scaffolds were washed with 1% (W/V) of Glycine solution to remove the unreacted glutaraldehyde.
2.2.2 Field Emission Scanning Electron Microscopy
The ross-section views of the composite scaffolds were investigated by FE-SEM (S-4700 model, HITACHI Company, Japan). The dispersion of the ZA into the nanocomposite samples was evaluated by energy dispersive spectroscopy (EDS). The ImageJ software was hired to examined pore size and the porosity percentage of each scaffold from the three SEM images by the following equation (Shahriarpanah et al., 2016):
In this equation, Ap is total area of pores in each cross-section and AT is total area of each cross-section from the SEM images.
2.2.3 Water Uptake
In order to examine the equilibrium water adsorption, the finalized scaffolds with the initial weight (Wo) were place into the deionized water for 24 h at 37°C. Then, the samples were pulled out and the excess water was wiped off by using a filter paper and weighed (Ws). The equilibrium water adsorption was gained by the following equation (Abdollahi Boraei et al., 2021a; Zadegan et al., 2019):
2.2.4 Fourier-Transform Infrared
FTIR spectroscopy (Spectrum 100, PerkinElmer Company, United Kingdom) was hired to investigate the changes in the structure of gelatin after HNTs and ZA-loaded HNTs addition. X-ray diffraction analysis (XRD; D8 ADVANCE diffractometer, BRUKER Company, United Kingdom) was done by using Cu-Kα radiation at 40 kV and speed of 2°/min to evaluate the crystallographic changes of (GEL) scaffolds after HNTs and ZA-loaded HNTs addition.
2.2.5 Mechanical Properties
The compressive behavior of the prepared scaffolds (GEL, GEL-HNT and GEL-HNT/ZA) were measured by the ZWICK/ROEL Z005 testing machine (ZWICK, Germany) with the cross-head speed of 1 mm/min.
2.3 Release Behavior of ZA
Drug release behavior of the scaffolds were measured by immersing and incubating the scaffolds in PBS at 37°C in a shaker incubator (90 rpm). The scaffold-released ZA level was examined by UV-Visible spectroscopy (NANODROP 2000c; Thermo Scientific Company, United States) at the wavelength of 210 nm at many times point (24, 48, 72 h and 7, 14 and 21 days).
2.4 Cellular Assays
2.4.1 Cell Culture Procedure
The hASCs (Shariati Hospital, Tehran, Iran) were cultured in Dulbecco’s modified Eagle’s medium (DMEM/F-12; Gibco, United States) with 12% fetal bovine serum and 1% Pen-strep (Gibco, United States), followed by incubation at humidified condition with 5% CO2 at 37°C. Moreover, the osteogenic agents (10,000 µM Beta-Glycerophosphate, 50 μg/ml l-Ascorbic acid and 10–4 μM Dexamethasone) were added to the medium. The prepared medium must be changing every 3 days. All cellular assays were performed by the second-passage of cells. Before seeding the cells on the scaffolds, all scaffolds were sterilized by UV irradiation for 20 min on each side of them.
2.4.2 Cytotoxicity of Prepared Scaffolds
Cytotoxicity of the scaffolds were measured by the 3-(4,5-Dimethylthiazol-2-yl)-2,5- Diphenyl Tetrazolium Bromide assay kit (MTT, Bioidea, Iran). The hASCs were seeded on sterilized scaffolds (20,000 cells/cm2). Then they were cultured in DMEM (15% FBS) at 5% CO2 and 37°C in the incubator for 1, 4 and 7 days. After that, 30 μl MTT was poured into each well, and incubation proceeded for 3 h. Then 200 μl DMSO (Bioidea, Iran) was added to cells and keep them for 30 min in a dark place. Finally, the absorption amounts were examined by using an ELISA plate reader (Stat Fax-2100, United States) at a wavelength of 545 nm.
2.4.3 Osteogenesis Assays
Alkaline phosphatase (ALP) activity assay was performed by using 200 μl of RIPA buffer. The total protein was extracted from hASCs cultured on Tissue Culture polystyrene (TCPS) and different scaffolds after 7 and 14 days during the period of study. In order to sedimentation of cell debris, the lysate was centrifuged at 1,200 rpm at 4°C for 5 min. Then, the supernatant was collected and ALP activity was examined with an ALP assay kit (Parsazmun, Tehran, Iran).
2.4.4 Calcium Assay
Calcium deposition on the scaffolds was examined by using Alizarin red staining (ARS) method. The hASCs cells were seeded on the scaffolds which were placed in the 24 well tissue culture plate. After 7 and 14 days of incubation, the fixation of cell-sample constructs was performed by the following instruction: 1) rinsing samples with PBS, 2) dehydration of samples through graded concentrations of ethanol 50, 70, 80 (for 15 min), 96, and 100% (for 8–10 min), respectively, 3) the Alizarin red-40 mM was poured on the samples and keep for 20–30 min. The deposited calcium, which is red/purple colour, was then observed using an inverted optical microscope (Nikon Eclipse TE2000-U, Japan).
2.5 Statistical Analysis
All tested were performed in triplicates and the data were presented as the mean ± standard deviation (SD). One-way ANOVA was used to evaluate the differences between the samples. Statistically significant levels were considered to be p < 0.05.
3 Results and Discussion
3.1 Characterization of the Nanocomposite Scaffolds
The morphology and pore size of the prepared scaffolds are shown in Figure 1. As expected, an interconnected network structure was observed in the scaffolds that is in line with the our previous study in which a gelatin-based scaffold containing HNTs and the hydrophilic drug strontium ranelate was synthesized, and the results showed a uniform structure with well-sized and interconnected cavities (Abdollahi Boraei et al., 2020b). Since the pore size distribution doesn’t significantly change with the addition of ZA, the prepared scaffolds show almost similar surface morphologies which consisted of homogenous porosities.
The pore size results showed that the Gel scaffold has the minimum pore size with the mean value of 80.94 ± 43.80 µm, while the pore size elevated to 175.57 ± 21.09 µm in Gel-HNT and 257.89 ± 16.11 µm in Gel-HNT/ZA scaffolds. As expected, the augmentation of HNTs and HNT/ZA leads to create bigger pores, which is in a desire range for BTE applications. In the studies, different numbers have been reported for the appropriateness of the pore size of scaffolds in tissue engineering, for example, in the article of Li et al., The number of 300–400 microns has been selected as the appropriate range (Li et al., 2016; Rashedi et al., 2021). Lee et al. Also considered the number 500 microns to be suitable for adhesion, differentiation, and proliferation of cells inside the scaffold (Lee D. J. et al., 2019). In our studies reported that the scaffolds with larger pore size (>100 µm) provide better matrices for bone regeneration (Abdollahi Boraei et al., 2021b). In general, this number (porosity) should be suitable for delivering nutrients into the scaffold and removing waste from the scaffold (Tolba et al., 2010; Ghazalian et al., 2022).
Table 1 displays the porosity percentage of the prepared scaffolds. A similar upward trend is observed for porosity. Increasing pore size and porosity probably can effects on the electrostatic repulsion forces between carboxyl and hydroxyl groups in gelatin (Type A; pI = 7–9) and HNTs, since both HNTs and gelatin are negatively charged at pH 7 (Abdollahi Boraei et al., 2021a).
The equilibrium water uptake results of the scaffolds are brought in Figure 2. The water uptake for the Gel-HNT/ZA scaffold was the highest (5.02 ± 0.316 (g/g)), while this value for the Gel and Gel-HNT scaffolds decreased to 4.66 ± 0.33 and 1.67 ± 0.369 (g/g), respectively. This increase can be related to the larger pore nature in the Gel-HNT/ZA scaffold and proved by such studies that the microstructure can affect the swelling ratio (Mirahmadi et al., 2013). The more swelling ratio resulted in more water adsorption that is suitable for dipper diffusion of nutrition and better removing of waste from the matrix (Mirahmadi et al., 2013).
FTIR analysis examines the chemical interaction of scaffold components that can determine the three-dimensional structure, the drug release properties, and the biological properties of the scaffold. Figure 3 shows the FTIR graphs of the scaffolds. As expected, in the gelatinous scaffold graph, characteristic gelatin peaks, including amide I, II, III, amide B, and amide A peaks, were observed at 1,698, 1,543, 1,236, 3,067, and 3,421 cm−1, respectively. In the previous study, where the gelatin-based scaffold was made by the freeze-drying method, the peaks mentioned above were observed in the scaffold structure and examined (Abdollahi Boraei et al., 2020a). After the HNTs are added to the scaffold, most of its peaks are overlapped with gelatin, a phenomenon that has been observed in the previous study (Abdollahi Boraei et al., 2021b). Only peaks of gelatin amide A (3,421 cm−1) and O-H stretching of HNTs (3,695 cm−1) shifted slightly, indicating successful incorporation of HNTs into the gelatin structure and even reinforcing the possibility of hydrogen bonding interactions between them. With the addition of ZA to the structure and synthesis of Gel-HNT/ZA nanocomposite scaffolds, new peaks appeared, these peaks include the following: P-O bond (1,300 and 1,322 cm−1), free hydroxyl group (3,492 cm−1), hydroxyl group (2,500–3,300 cm−1) (Paris et al., 2015; Chen et al., 2020) that is the reason for the successful addition of ZA to the structure.
Figure 4 shows the diffraction pattern of a gelatinous scaffold with a wide peak at 20.25°, which is related to the crystalline structure of the gelatin triple helical, which has been reported in several studies (Jalaja et al., 2015). In general, the HNT pattern has many sharp peaks (Liao et al., 2016). A peak at 20.3° is observed which is one of the characteristic peaks of HNT that related to (020/110) plane (Liao et al., 2016). The location of this peak has not changed due to the scaffolding production process, which indicates that the HNT layers do not change and that the HNT and gelatin do not intercalate (White et al., 2012). As a result of the addition of ZA to the Gel-HNT scaffold, a small increase in the intensity of the Gel-HNT scaffold peaks occurred, which could be due to the penetration of ZA into the silicate layers of the HNTs. However, due to the absence of ZA characteristic peaks in the graph, it can be concluded that ZA is not completely crystalline in structure. This may be due to the very low concentration of ZA (˃10–4 mol/L) in the structure that is in line with the results of a previous study in which ZA was loaded into a composite structure and coated on a magnesium implant containing strontium (Li et al., 2019).
Table 2 shows the results of the mechanical compressive strength test of scaffolds. As can be seen, the Gel scaffold has the lowest mechanical strength (σ = 10.27 ± 1.58 MPa), followed by the Gel-HNT scaffold with (σ = 20.92 ± 2.16 MPa) and Gel-HNT/ZA scaffold with (σ = 26.18 ± 2.9 MPa). Despite the increase in pore size in Gel-HNT and Gel-HNT/ZA scaffolds, which should have led to a decrease in mechanical strength, the strength of these samples has increased. The reason for this can be related to the presence of HNTs, which is a ceramic with very high mechanical properties, and the presence of HNT in the structure may lead to the bearing and transfer of force throughout the structure and increase the mechanical properties of scaffolds containing HNTs. In several studies, the effect of adding HNT to biopolymers was investigated, all of which showed an increase in the mechanical properties of the resulting structure (Liu et al., 2013; Liu et al., 2015). Increasing the strength of synthesized tissue engineering scaffolds is considered as one of the practical advantages because scaffolds must act as temporary support against stresses and forces until the tissue is completely repaired (Liu et al., 2015).
3.2 In vitro Release Study
Recent studies have shown that local delivery of osteogenesis drugs with a controlled behavior can be used as a way to improve large and severe bone defects with low side effects (Boraei et al., 2020). The release behavior of ZA was initiated by a low burst mode and then continued via a stable release with a low rate. Also, the release profile successfully extended to 21 days, meaning proper time to complete in vitro osteogenic differentiation of stem cells (Bou Assaf et al., 2019) (Figure 5). Of course, the actual burst release is reduced through bonding between HNT and ZA. In addition, the low crystallinity of the scaffolds with more ZA facilitated the water diffusion into the scaffolds and consequently increased the ZA release from the samples. These results are in accordance with the previous study (Karavelidis et al., 2011), which proved that the ZA release rate is amplified by lowering the crystallinity of the polymer matrix.
3.3 hASCs Proliferation and Differentiation
Cell viability and cytocompatibility of the scaffolds are shown in Figure 6. Human Adipose Stem Cells (hASCs) were cultured onto the samples, and an MTT assay was done. Cell proliferation was investigated after 1, 4, and 7 days. In a study by Davydenko et al., OD in a sample with pure gelatin scaffold was higher than OD of TCPs, which can be considered due to the presence of more sites for cell-matrix interaction. These places are mostly due to the presence of interconnected micron porosity (Davidenko et al., 2016). These results were also observed in this study, which shows the importance of interconnected porous structures. According to the results, both Gel-HNT and Gel-HNT/ZA showed more proliferation than Gel sample during the days of culture, especially in ZA-containing scaffold. By adding HNTs nanorods to the structure, the surface-to-volume ratio increases dramatically, and consequently the cell-matrix interaction increase, which in turn increases cell proliferation and differentiation, which is consistent with previous studies (Ji et al., 2017).
Alkaline phosphatase (ALP) activity assay was used to investigate the osteogenic ability of hASCs. This enzyme is one of the most famous early markers of osteogenesis. There are some researches that demonstrated the role of ALP in osteogenic differentiation (Ardeshirylajimi et al., 2015). The ALP is the final marker for stem cell osteogenic differentiation that promotes the mineralization of calcium (Boraei et al., 2020). This test was performed on scaffolds for 7 and 14 days (Figure 7). The results showed a higher expression of the activity of samples containing ZA on day 14. There was also a slight increase in ALP on day 7. It is important to note that ALP values for all scaffolds were significantly higher than those calculated for TCPs. In addition, the ALP amount is considerably more in the samples including ZA, suggesting the speed up of osteogenic differentiation of seeded hASCs by the scaffold-released ZA. As reported previously, maximum ALP activity is caused by enhancement in the mineralization (Santo et al., 2012).
FIGURE 7. Alkaline phosphatase (ALP) activity of (Gel, Gel-HNT and Gel-HNT/ZA) scaffolds and tissue culture polystyrene (TCPS) at 7 and 14 days, during osteogenic differentiation (p < 0.05).
The state of mineralization, which is the formation of inorganic calcium, was also investigated for 7, 14 and 21 days (Figure 8). This state of mineralization (calcium deposition) acts as the late marker of osteogenesis were investigated by Alizarin Red Staining (ARS) (Veernala et al., 2019). In this analysis, the red dots after imaging indicate the amount of calcium deposition at specific times. The amount of deposited calcium was remarkably increased with increasing the incubation time and adding the ZA until 21st day. On day 14, ZA release from the scaffolds caused a large difference in the amount of calcium deposited. The Bone Mineral Density (BMD) and osteogenic ability of ZA have been widely investigated and different mechanisms have been discussed (Pavón de Paz et al., 2019; Jin et al., 2020). In previous studies on ZA, the rate of increase in calcium deposits was observed with increasing time, the amount of calcium islets on the 14th day was significantly higher than the 7th day, which is consistent with our present study that the deposits Calcium has increased over time and the amount of ZA in the scaffold has increased (Raina et al., 2020; Demir-Oğuz and Ege, 2021).
FIGURE 8. Alizarin red staining of culture hASCs on the (A) Gel, (B) Gel-HNT and (C) Gel-HNT/ZA Scaffolds at 7, 14 and 21 days.
Conclusion
The present study aimed to inset a novel nanocomposite scaffold to accelerate osteogenesis and deliver enough amount of Zoledronic Acid (ZA) to the bone cells in a suitable and continues manner for osteogenesis. The size of the pores in the scaffold containing ZA reached about 257 microns, which is completely suitable for use in bone tissue engineering. The XRD results showed that the ZA was molecularly scattered in the scaffold structure and addition of ZA diminished the crystallinity of the nanocomposite scaffolds. FTIR and EDS results were proved the successful loading of ZA in the samples. The in vitro release assay showed that ZA has displayed a low primary burst release (15%) and then was stable and controlled release up to 21 days (about 49%). The results of Gel-HNT and Gel-HNT/ZA showed higher pore size, porosity, mechanical properties, degradation rate, and water adsorption in comparison with Gel scaffold. Cellular assays on hASCs during 7 and 14 days of culture, demonstrated growth cell viability on all Gel-based scaffolds with and without HNT and ZA. ALP activity assay significantly increased after ZA adding from 0.553 to 0.718. Also, calcium deposition assay completely increased after ZA adding. Hence, Gel-HNT/ZA could be proposed as a capable nanocomposite scaffold for enhancing cell proliferation, osteogenic differentiation, and improving bone regeneration.
Data Availability Statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Author Contributions
SA and MM contributed to the design of the study and organized the database. SA wrote sections of the manuscript. ME performed the statistical analysis and wrote the first draft of the manuscript. MV performed the statistical analysis and wrote the first draft of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Abdollahi Boraei, S. B., Nourmohammadi, J., Bakhshandeh, B., Dehghan, M. M., Gholami, H., Calle Hernández, D., et al. (2021a). Enhanced Osteogenesis of Gelatin-Halloysite Nanocomposite Scaffold Mediated by Loading Strontium Ranelate. Int. J. Polymeric Mater. Polymeric Biomater. 70, 392–402. doi:10.1080/00914037.2020.1725754
Abdollahi Boraei, S. B., Nourmohammadi, J., Bakhshandeh, B., Dehghan, M. M., Gholami, H., Gonzalez, Z., et al. (2021b). Capability of Core-Sheath Polyvinyl Alcohol-Polycaprolactone Emulsion Electrospun Nanofibrous Scaffolds in Releasing Strontium Ranelate for Bone Regeneration. Biomed. Mater. 16, 025009. doi:10.1088/1748-605x/abdb07
Abdollahi Boraei, S. B., Nourmohammadi, J., Bakhshandeh, B., Dehghan, M. M., Gonzalez, Z., and Ferrari, B. (2020a). The Effect of Protelos Content on the Physicochemical, Mechanical and Biological Properties of Gelatin-Based Scaffolds. J. Appl. Biotechnol. Rep. 7, 41–47. doi:10.1080/00914037.2020.1725754
Abdollahi Boraei, S. B., Nourmohammadi, J., Sadat Mahdavi, F., Yus, J., Ferrandez-Montero, A., Sanchez-Herencia, A. J., et al. (2020b). Effect of SrR Delivery in the Biomarkers of Bone Regeneration during the In Vitro Degradation of HNT/GN Coatings Prepared by EPD. Colloids Surf. B: Biointerfaces 190, 110944. doi:10.1016/j.colsurfb.2020.110944
Ardeshirylajimi, A., Mossahebi-Mohammadi, M., Vakilian, S., Langroudi, L., Seyedjafari, E., Atashi, A., et al. (2015). Comparison of Osteogenic Differentiation Potential of Human Adult Stem Cells Loaded on Bioceramic-Coated Electrospun Poly (L-Lactide) Nanofibres. Cell Prolif. 48, 47–58. doi:10.1111/cpr.12156
Benford, H. L., Mcgowan, N. W. A., Helfrich, M. H., Nuttall, M. E., and Rogers, M. J. (2001). Visualization of Bisphosphonate-Induced Caspase-3 Activity in Apoptotic Osteoclasts In Vitro. Bone 28, 465–473. doi:10.1016/s8756-3282(01)00412-4
Bou Assaf, R., Fayyad-Kazan, M., Al-Nemer, F., Makki, R., Fayyad-Kazan, H., Badran, B., et al. (2019). Evaluation of the Osteogenic Potential of Different Scaffolds Embedded with Human Stem Cells Originated from Schneiderian Membrane: an In Vitro Study. Biomed. Res. Int. 2019, 1–10. doi:10.1155/2019/2868673
Burg, K. J. L., Porter, S., and Kellam, J. F. (2000). Biomaterial Developments for Bone Tissue Engineering. Biomaterials 21, 2347–2359. doi:10.1016/s0142-9612(00)00102-2
Carbone, E. J., Jiang, T., Nelson, C., Henry, N., and Lo, K. W.-H. (2014). Small Molecule Delivery through Nanofibrous Scaffolds for Musculoskeletal Regenerative Engineering. Nanomedicine: Nanotechnology, Biol. Med. 10, 1691–1699. doi:10.1016/j.nano.2014.05.013
Cartmell, S. (2009). Controlled Release Scaffolds for Bone Tissue Engineering. J. Pharm. Sci. 98, 430–441. doi:10.1002/jps.21431
Chen, S., Wan, P., Zhang, B., Yang, K., and Li, Y. (2020). Facile Fabrication of the Zoledronate-Incorporated Coating on Magnesium alloy for Orthopaedic Implants. J. Orthopaedic Translation 22, 2–6. doi:10.1016/j.jot.2019.09.007
Coxon, F. P., Helfrich, M. H., Van'T Hof, R., Sebti, S., Ralston, S. H., Hamilton, A., et al. (2000). Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298. J. Bone Miner Res. 15, 1467–1476. doi:10.1359/jbmr.2000.15.8.1467
Davidenko, N., Schuster, C. F., Bax, D. V., Farndale, R. W., Hamaia, S., Best, S. M., et al. (2016). Evaluation of Cell Binding to Collagen and Gelatin: a Study of the Effect of 2D and 3D Architecture and Surface Chemistry. J. Mater. Sci. Mater. Med. 27, 148. doi:10.1007/s10856-016-5763-9
Demir-Oğuz, Ö., and Ege, D. (2021). Effect of Zoledronic Acid and Graphene Oxide on the Physical and In Vitro Properties of Injectable Bone Substitutes. Mater. Sci. Eng. C 120, 111758. doi:10.1016/j.msec.2020.111758
Flahiff, C. M., Blackwell, A. S., Hollis, J. M., and Feldman, D. S. (1996). Analysis of a Biodegradable Composite for Bone Healing. J. Biomed. Mater. Res. 32, 419–424. doi:10.1002/(sici)1097-4636(199611)32:3<419::aid-jbm15>3.0.co;2-b
Gage, M. J., Liporace, F. A., Egol, K. A., and Mclaurin, T. M. (2018). Management of Bone Defects in Orthopedic Trauma. Bull. NYU Hosp. Jt. Dis. 76, 4–8.
Ghazalian, M., Afshar, S., Rostami, A., Rashedi, S., and Bahrami, S. H. (2022). Fabrication and Characterization of Chitosan-Polycaprolactone Core-Shell Nanofibers Containing Tetracycline Hydrochloride. Colloids Surf. A: Physicochemical Eng. Aspects 636, 128163. doi:10.1016/j.colsurfa.2021.128163
Guerado, E., and Caso, E. (2017). Challenges of Bone Tissue Engineering in Orthopaedic Patients. Wjo 8, 87. doi:10.5312/wjo.v8.i2.87
Jalaja, K., Naskar, D., Kundu, S. C., and James, N. R. (2015). Fabrication of Cationized Gelatin Nanofibers by Electrospinning for Tissue Regeneration. Rsc Adv. 5, 89521–89530. doi:10.1039/C5RA10384C
Ji, L., Qiao, W., Zhang, Y., Wu, H., Miao, S., Cheng, Z., et al. (2017). A Gelatin Composite Scaffold Strengthened by Drug-Loaded Halloysite Nanotubes. Mater. Sci. Eng. C 78, 362–369. doi:10.1016/j.msec.2017.04.070
Jin, Z. H., Wang, S. F., and Liao, W. (2020). Zoledronic Acid Accelerates Osteogenesis of Bone Marrow Mesenchymal Stem Cells by Attenuating Oxidative Stress via the SIRT3/SOD2 Pathway and Thus Alleviates Osteoporosis. Eur. Rev. Med. Pharmacol. Sci. 24, 2095–2101. doi:10.26355/eurrev_202002_20389
Karavelidis, V., Karavas, E., Giliopoulos, D., Papadimitriou, S., and Bikiaris, D. (2011). Evaluating the Effects of Crystallinity in New Biocompatible Polyester Nanocarriers on Drug Release Behavior. Int. J. Nanomedicine 6, 3021–3032. doi:10.2147/IJN.S26016
Kim, T., See, C. W., Li, X., and Zhu, D. (2020). Orthopedic Implants and Devices for Bone Fractures and Defects: Past, Present and Perspective. Engineered Regen. 1, 6–18. doi:10.1016/j.engreg.2020.05.003
Lambrinoudaki, I., Christodoulakos, G., and Botsis, D. (2006). Bisphosphonates. Ann. N.Y Acad. Sci. 1092, 397–402. doi:10.1196/annals.1365.036
Lee, D. J., Kwon, J., Kim, Y. I., Wang, X., Wu, T. J., Lee, Y. T., et al. (2019). Effect of Pore Size in Bone Regeneration Using Polydopamine‐laced Hydroxyapatite Collagen Calcium Silicate Scaffolds Fabricated by 3D Mould Printing Technology. Orthod. Craniofac. Res. 22, 127–133. doi:10.1111/ocr.12261
Lee, Y.-J., Lee, S.-C., Jee, S. C., Sung, J.-S., and Kadam, A. A. (2019). Surface Functionalization of Halloysite Nanotubes with Supermagnetic Iron Oxide, Chitosan and 2-D Calcium-Phosphate Nanoflakes for Synergistic Osteoconduction Enhancement of Human Adipose Tissue-Derived Mesenchymal Stem Cells. Colloids Surf. B: Biointerfaces 173, 18–26. doi:10.1016/j.colsurfb.2018.09.045
Lee, Y.-M., Seol, Y.-J., Lim, Y.-T., Kim, S., Han, S.-B., Rhyu, I.-C., et al. (2001). Tissue-engineered Growth of Bone by Marrow Cell Transplantation Using Porous Calcium Metaphosphate Matrices. J. Biomed. Mater. Res. 54, 216–223. doi:10.1002/1097-4636(200102)54:2<216::aid-jbm8>3.0.co;2-c
Li, G., Wang, L., Pan, W., Yang, F., Jiang, W., Wu, X., et al. (2016). In Vitro and In Vivo Study of Additive Manufactured Porous Ti6Al4V Scaffolds for Repairing Bone Defects. Sci. Rep. 6, 34072. doi:10.1038/srep34072
Li, M., Wan, P., Wang, W., Yang, K., Zhang, Y., and Han, Y. (2019). Regulation of Osteogenesis and Osteoclastogenesis by Zoledronic Acid Loaded on Biodegradable Magnesium-Strontium alloy. Sci. Rep. 9, 933. doi:10.1038/s41598-018-37091-8
Liao, L., Lv, G., Cai, D., and Wu, L. (2016). The Sequential Intercalation of Three Types of Surfactants into Sodium Montmorillonite. Appl. Clay Sci. 119, 82–86. doi:10.1016/j.clay.2015.08.003
Liu, D., and Dixit, V. (1997). Porous Materials for Tissue Engineering. Switzerland: Trans Tech Pub.
Liu, M., Dai, L., Shi, H., Xiong, S., and Zhou, C. (2015). In Vitro evaluation of Alginate/halloysite Nanotube Composite Scaffolds for Tissue Engineering. Mater. Sci. Eng. C 49, 700–712. doi:10.1016/j.msec.2015.01.037
Liu, M., Wu, C., Jiao, Y., Xiong, S., and Zhou, C. (2013). Chitosan-halloysite Nanotubes Nanocomposite Scaffolds for Tissue Engineering. J. Mater. Chem. B 1, 2078–2089. doi:10.1039/c3tb20084a
Mirahmadi, F., Tafazzoli-Shadpour, M., Shokrgozar, M. A., and Bonakdar, S. (2013). Enhanced Mechanical Properties of Thermosensitive Chitosan Hydrogel by Silk Fibers for Cartilage Tissue Engineering. Mater. Sci. Eng. c 33, 4786–4794. doi:10.1016/j.msec.2013.07.043
Nancollas, G. H., Tang, R., Phipps, R. J., Henneman, Z., Gulde, S., Wu, W., et al. (2006). Novel Insights into Actions of Bisphosphonates on Bone: Differences in Interactions with Hydroxyapatite. Bone 38, 617–627. doi:10.1016/j.bone.2005.05.003
Paris, J. L., Román, J., Manzano, M., Cabañas, M. V., and Vallet-Regí, M. (2015). Tuning Dual-Drug Release from Composite Scaffolds for Bone Regeneration. Int. J. pharmaceutics 486, 30–37. doi:10.1016/j.ijpharm.2015.03.048
Park, J. B., and Bronzino, J. (2000). The Biomedical Engineering Handbook, 4. Boca Raton, FL: CRC Press, 1–8.
Parks, J., and Lakes, R. (1992). Metallic Implant materialsBiomaterials—An Introduction. New York: Plenum Press, 75.
Pavón de Paz, I., Rosado Sierra, J. A., Pérez Blanco, C., Modroño Móstoles, N., Guijarro de Armas, G., and Navea Aguilera, C. (2019). Acute and Long-Term Effects of Zoledronate in Adult Patients with Osteogenesis Imperfecta. An Observational Spanish Study with Five Years of Follow-Up. Endocrinología, Diabetes y Nutrición (English ed.) 66, 108–116. doi:10.1016/j.endien.2019.02.001
Raina, D. B., Matuszewski, L. M., Vater, C., Bolte, J., Isaksson, H., Lidgren, L., et al. (2020). A Facile One-Stage Treatment of Critical Bone Defects Using a Calcium Sulfate/hydroxyapatite Biomaterial Providing Spatiotemporal Delivery of Bone Morphogenic Protein-2 and Zoledronic Acid. Sci. Adv. 6, eabc1779. doi:10.1126/sciadv.abc1779
Rashedi, S., Afshar, S., Rostami, A., Ghazalian, M., and Nazockdast, H. (2021). Co-electrospun Poly(lactic Acid)/gelatin Nanofibrous Scaffold Prepared by a New Solvent System: Morphological, Mechanical and In Vitro Degradability Properties. Int. J. Polymeric Mater. Polymeric Biomater. 70, 545–553. doi:10.1080/00914037.2020.1740987
Santo, V. E., Duarte, A. R. C., Popa, E. G., Gomes, M. E., Mano, J. F., and Reis, R. L. (2012). Enhancement of Osteogenic Differentiation of Human Adipose Derived Stem Cells by the Controlled Release of Platelet Lysates from Hybrid Scaffolds Produced by Supercritical Fluid Foaming. J. controlled release 162, 19–27. doi:10.1016/j.jconrel.2012.06.001
Shahriarpanah, S., Nourmohammadi, J., and Amoabediny, G. (2016). Fabrication and Characterization of Carboxylated Starch-Chitosan Bioactive Scaffold for Bone Regeneration. Int. J. Biol. macromolecules 93, 1069–1078. doi:10.1016/j.ijbiomac.2016.09.045
Tolba, E., Abd-Elhady, B., Elkholy, B., Elkady, H., and Eltonsi, M. (2010). Biomimetic Synthesis of Guided-Tissue Regeneration Hydroxyapatite/polyvinyl Alcohol Nanocomposite Scaffolds: Influence of Alginate on Mechanical and Biological Properties. J. Am. Sci. 6, 239–249.
Veernala, I., Giri, J., Pradhan, A., Polley, P., Singh, R., and Yadava, S. K. (2019). Effect of Fluoride Doping in Laponite Nanoplatelets on Osteogenic Differentiation of Human Dental Follicle Stem Cells (hDFSCs). Sci. Rep. 9, 915–15. doi:10.1038/s41598-018-37327-7
White, R. D., Bavykin, D. V., and Walsh, F. C. (2012). The Stability of Halloysite Nanotubes in Acidic and Alkaline Aqueous Suspensions. Nanotechnology 23, 065705. doi:10.1088/0957-4484/23/6/065705
Wiese, A., and Pape, H. C. (2010). Bone Defects Caused by High-Energy Injuries, Bone Loss, Infected Nonunions, and Nonunions. Orthop. Clin. North America 41, 1–4. doi:10.1016/j.ocl.2009.07.003
Xu, T., Sheng, L., He, L., Weng, J., and Duan, K. (2020). Enhanced Osteogenesis of Hydroxyapatite Scaffolds by Coating with BMP-2-Loaded Short Polylactide Nanofiber: a New Drug Loading Method for Porous Scaffolds. Regen. Biomater. 7, 91–98. doi:10.1093/rb/rbz040
Yang, X.-J., Wang, F.-Q., Lu, C.-B., Zou, J.-W., Hu, J.-B., Yang, Z., et al. (2020). Modulation of Bone Formation and Resorption Using a Novel Zoledronic Acid Loaded Gelatin Nanoparticles Integrated Porous Titanium Scaffold: An In Vitro and In Vivo Study. Biomed. Mater. 15, 055013. doi:10.1088/1748-605x/ab8720
Zadegan, S., Nourmohammadi, J., Vahidi, B., and Haghighipour, N. (2019). An Investigation into Osteogenic Differentiation Effects of Silk Fibroin-Nettle (Urtica Dioica L.) Nanofibers. Int. J. Biol. macromolecules 133, 795–803. doi:10.1016/j.ijbiomac.2019.04.165
Zare, Y., and Rhee, K. Y. (2021a). A Model for Tensile Modulus of Halloysite-Nanotube-Based Samples Assuming the Distribution and Networking of Both Nanoparticles and Interphase Zone after Mechanical Percolation. Mech. Adv. Mater. Structures, 1–10. doi:10.1080/15376494.2021.1962457
Zare, Y., and Rhee, K. Y. (2021b). A Simple Model for Determining the Strength of Polymer Halloysite Nanotube Systems. Composites B: Eng. 227, 109411. doi:10.1016/j.compositesb.2021.109411
Zare, Y., and Rhee, K. Y. (2022). Expansion of Takayanagi Model by Interphase Characteristics and Filler Size to Approximate the Tensile Modulus of Halloysite-Nanotube-Filled System. J. Mater. Res. Technol. 16, 1628–1636. doi:10.1016/j.jmrt.2021.12.082
Zare, Y., Rhee, K. Y., and Park, S.-J. (2021). An Applicable Model for the Modulus of Polymer Halloysite Nanotubes Samples by the Characteristics of Halloysite Nanotubes, Interphase Zone and Filler/interphase Network. Colloids Surf. A: Physicochemical Eng. Aspects 628, 127330. doi:10.1016/j.colsurfa.2021.127330
Keywords: zoledronic acid, halloysite, gelatin, nanocomposite, osteogenesis, scaffolds
Citation: Abdulahy SB, Esmaeili Bidhendi M, Vaezi MR and Moosazadeh Moghaddam M (2022) Osteogenesis Improvement of Gelatin-Based Nanocomposite Scaffold by Loading Zoledronic Acid. Front. Bioeng. Biotechnol. 10:890583. doi: 10.3389/fbioe.2022.890583
Received: 06 March 2022; Accepted: 08 April 2022;
Published: 25 April 2022.
Edited by:
Kyong Rhee, Kyung Hee University, South KoreaReviewed by:
Amir Rostami, Persian Gulf University, IranJafar Khademzadeh Yeganeh, Qom University of Technology, Iran
Copyright © 2022 Abdulahy, Esmaeili Bidhendi, Vaezi and Moosazadeh Moghaddam. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mehrdad Moosazadeh Moghaddam, bW0uZ2VuZXRpY3NAZ21haWwuY29t, cnNyLm1vb3NhemFkZWhAYm1zdS5hYy5pcg==